Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss YMAB - Y-mAbs Therapeutics, Inc.
2.26 M
LAST VALUE
30.42%
2 YEAR CAGR
114.38%
5 YEAR CAGR
0.00%
10 YEAR CAGR